{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:23:56Z","timestamp":1777368236243,"version":"3.51.4"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jjcc.2017.07.012","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T21:45:52Z","timestamp":1505252752000},"page":"10-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Impact of nonfasting triglycerides\/high-density lipoprotein cholesterol ratio on secondary prevention in patients treated with statins"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2461-9241","authenticated-orcid":false,"given":"Ichiro","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Misaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mizuki","family":"Kurozumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsunetatsu","family":"Nanba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichiro","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jjcc.2017.07.012_bib0175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the global burden of disease study 2013","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0180","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0185","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ypmed.2011.02.019","article-title":"Low-density lipoprotein cholesterol and risk of coronary heart disease among Japanese men and women: the Coronary Risk in Community Study (CIRCS)","volume":"52","author":"Imano","year":"2011","journal-title":"Prev Med"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0190","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0195","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0200","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1253\/circj.72.1218","volume":"72","author":"Itakura","year":"2008","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0205","doi-asserted-by":"crossref","first-page":"517","DOI":"10.5551\/jat.15792","article-title":"Executive summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan \u2013 2012 Version","volume":"20","author":"Teramoto","year":"2013","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0210","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"The Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0215","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 AHA\/ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0220","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.jacc.2014.06.1159","article-title":"2013 ACC\/AHA guideline recommends fixed-dose strategies instead of targeted goals to lower blood cholesterol","volume":"64","author":"Smith","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0225","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ahj.2008.08.010","article-title":"Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines","volume":"157","author":"Sachdeva","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0230","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2015.12.018","article-title":"Management of residual risk after statin therapy","volume":"245","author":"Reith","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0235","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2147\/CEOR.S107992","article-title":"Residual cardiovascular risk in patients who received lipid-lowering treatment in real-life setting: retrospective study","volume":"8","author":"Perrone","year":"2016","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0240","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa064278","article-title":"HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0245","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.atherosclerosis.2015.05.010","article-title":"High-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after percutaneous coronary intervention: a report from the CREDO-Kyoto registry cohort-2","volume":"242","author":"Izuhara","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0250","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.atherosclerosis.2010.03.006","article-title":"All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridemia: a long-term prospective resistry study","volume":"211","author":"Neil","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0255","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/aje\/153.5.490","article-title":"Serum triglycerides and risk of coronary heart disease among Japanese men and women","volume":"153","author":"Iso","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0260","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1001\/jama.298.3.299","article-title":"Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women","volume":"298","author":"Nordestgaard","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0265","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0021-9150(92)90012-6","article-title":"Relationship of triglycerides and HDL cholesterol in hypertriglyceridemia","volume":"92","author":"Avogaro","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0270","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1161\/01.CIR.96.8.2520","article-title":"Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction","volume":"96","author":"Gaziano","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0275","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.2174\/0929867054546609","article-title":"Clinical relevance of postprandial lipaemia","volume":"12","author":"Kolovou","year":"2005","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0280","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1093\/eurheartj\/ehw152","volume":"37","author":"Nordestgaard","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0285","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1007\/s00125-006-0262-z","article-title":"Postprandial lipaemia induces an acute decrease of insulin sensitivity in healthy men independently of plasma NEFA levels","volume":"49","author":"Pedrini","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0290","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.amjcard.2012.02.016","article-title":"Relation among the plasma triglyceride\/high-density lipoprotein cholesterol concentration ratio, insulin resistance, and associated cardiometabolic risk factors in men and women","volume":"109","author":"Salazar","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0295","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1291\/hypres.31.2027","article-title":"Impact of metabolic syndrome components on the incidence of cardiovascular disease in a general urban Japanese population: the Suita study","volume":"31","author":"Kokubo","year":"2008","journal-title":"Hypertens Res"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0300","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1253\/circj.CJ-09-0264","article-title":"Risk of smoking and metabolic syndrome for incidence of cardiovascular disease: comparison of relative contribution in urban Japanese population: the Suita study","volume":"73","author":"Higashiyama","year":"2009","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0305","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11906-009-0010-0","article-title":"Vascular insulin resistance: a potential link between cardiovascular and metabolic diseases","volume":"11","author":"Schulman","year":"2009","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0310","doi-asserted-by":"crossref","first-page":"202","DOI":"10.5551\/jat.13.202","article-title":"Prevalence of metabolic syndrome in the general Japanese population in 2000","volume":"13","author":"Arai","year":"2006","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0315","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0022-2275(20)35731-X","article-title":"Association of plasma triglyceride concentration and LDL particle diameter, density, and chemical composition with premature coronary artery disease in men and women","volume":"34","author":"Coresh","year":"1993","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0320","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/clinchem\/44.6.1224","article-title":"Remnant lipoprotein cholesterol and triglyceride reference ranges from the Framingham Heart Study","volume":"44","author":"McNamara","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0325","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.95.1.69","article-title":"Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Qu\u00e9bec Cardiovascular Study","volume":"95","author":"Lamarche","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0330","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1253\/circj.CJ-14-0380","article-title":"High remnant lipoprotein predicts recurrent cardiovascular events on statin treatment after acute coronary syndrome","volume":"78","author":"Nguyen","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0335","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s41043-016-0067-8","article-title":"Optimal cutoff of the triglyceride to high-density lipoprotein cholesterol ratio to direct cardiovascular risk factors among Han adults in Xinjiang","volume":"35","author":"Li","year":"2016","journal-title":"J Health Popul Nutr"},{"key":"10.1016\/j.jjcc.2017.07.012_bib0340","doi-asserted-by":"crossref","first-page":"e0123521","DOI":"10.1371\/journal.pone.0123521","article-title":"The association between triglyceride\/high-density lipoprotein cholesterol ratio and all-cause mortality in acute coronary syndrome after coronary revascularization","volume":"10","author":"Wan","year":"2015","journal-title":"PLOS ONE"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508717302125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0914508717302125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T12:57:28Z","timestamp":1760273848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0914508717302125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0914508717302125"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2017.07.012","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of nonfasting triglycerides\/high-density lipoprotein cholesterol ratio on secondary prevention in patients treated with statins","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2017.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}